-
- 抗原 See all BSCL2 抗体
- BSCL2 (Berardinelli-Seip Congenital Lipodystrophy 2 (Seipin) (BSCL2))
-
抗原表位
- AA 263-354
-
适用
- 人
-
宿主
- 小鼠
-
克隆类型
- 多克隆
-
标记
- This BSCL2 antibody is un-conjugated
-
应用范围
- Western Blotting (WB), ELISA
- 原理
- Mouse polyclonal antibody raised against a partial recombinant BSCL2.
- 序列
- WPRHRFSLQV NIRKRDNSRK EVQRRISAHQ PGPEGQEEST PQSDVTEDGE SPEDPSGTEG QLSEEEKPDQ QPLSGEEELE PEASDGSGSW ED
- 交叉反应
- 人
- 产品特性
- Antibody Reactive Against Recombinant Protein.
- 免疫原
- BSCL2 (NP_116056, 263 a.a. ~ 354 a.a) partial recombinant protein with GST tag.
-
-
- 应用备注
- Optimal working dilution should be determined by the investigator.
- 限制
- 仅限研究用
-
- 状态
- Liquid
- 缓冲液
- 50 % glycerol
- 注意事项
- Aliquot to avoid repeated freezing and thawing.
- 储存条件
- -20 °C
- 储存方法
- Store at -20°C or lower. Aliquot to avoid repeated freezing and thawing.
-
-
Adipose-specific knockout of SEIPIN/BSCL2 results in progressive lipodystrophy." in: Diabetes, Vol. 63, Issue 7, pp. 2320-31, (2014) (PubMed).
: "Overexpression of a short human seipin/BSCL2 isoform in mouse adipose tissue results in mild lipodystrophy." in: American journal of physiology. Endocrinology and metabolism, Vol. 302, Issue 6, pp. E705-13, (2012) (PubMed).
: "
-
Adipose-specific knockout of SEIPIN/BSCL2 results in progressive lipodystrophy." in: Diabetes, Vol. 63, Issue 7, pp. 2320-31, (2014) (PubMed).
-
-